| Literature DB >> 33243626 |
Sharon Baumel-Alterzon1, Liora S Katz1, Gabriel Brill2, Adolfo Garcia-Ocaña1, Donald K Scott3.
Abstract
Prolonged hyperglycemia is toxic to pancreatic β cells, generating excessive reactive oxygen species, defective glucose-stimulated insulin secretion, decreased insulin production, and eventually β cell death and diabetes. Nrf2 is a master regulator of cellular responses to counteract dangerous levels of oxidative stress. Maintenance of β cell mass depends on Nrf2 to promote the survival, function, and proliferation of β cells. Indeed, Nrf2 activation decreases inflammation, increases insulin sensitivity, reduces body weight, and preserves β cell mass. Therefore, numerous pharmacological activators of Nrf2 are being tested in clinical trials for the treatment of diabetes and diabetic complications. Modulating Nrf2 activity in β cells is a promising therapeutic approach for the treatment of diabetes.Entities:
Keywords: Nrf2; diabetes; metabolic stress; oxidative stress; pancreatic beta cell; proliferation
Mesh:
Substances:
Year: 2020 PMID: 33243626 PMCID: PMC7746592 DOI: 10.1016/j.tem.2020.11.002
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015